Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desacyl ghrelin and insulin sensitivity in men with type 2 diabetes
2013-000022-63Phase 2Completed
- Sponsor
- Aarhus University
- Start
- Feb 2014
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of unacylated ghrelin in type 2 diabetes mellitus (T2DM) and insulin resistance (IR), sponsored by Aarhus University. Primary endpoint: Insulin sensitivity. Started Feb 2014; status: completed.
02
Drugs
unacylated ghrelin
03
Conditions
type 2 diabetes mellitus (T2DM)insulin resistance (IR)
Beyond the preview
Go deeper on 2013-000022-63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000022-63.